Developing the novel therapies targeting vascular permeability, a precursor to prevalent diseases like atherosclerosis requires rigorous preclinical testing. However, complex fabrication methods often hinder the reproducibility and high-throughput
Connectez-vous ou commencez votre essai gratuit pour accéder à ce contenu.